Skip to main content
Premium Trial:

Request an Annual Quote

Agilent, University of Rouen, Singapore Institute Developing Tools for Biologics, Vaccine Analysis

NEW YORK (GenomeWeb News) – Agilent Technologies, a University of Rouen laboratory, and the Bioprocessing Technology Institute in Singapore have signed a memorandum of understanding for the development of tools to analyze biologics and vaccines.

BTI is developing methods of producing and analyzing biologics in animal cells, it said, and the Glyco-MEV lab at the University of Rouen specializes in producing molecules used in biologics, including antibodies, growth factors, and recombinant proteins, in plant systems. As part of the deal, Agilent will provide technological expertise resulting in the development of sensitive, high-throughput methods "that are particularly adapted to the analysis of biopharmaceuticals," BIT said. The institute is part of Singapore's Agency for Science, Technology, and Research.

Rudolf Grimm, Agilent's director of science and technology and manager of collaborations in the Asia-Pacific region, added that the collaboration will enable researchers to optimize glycan analytical workflows on his firm's HPLC-Chip/MS platform.

The Glyco-MEV lab also will become Agilent's glycomics reference site in Europe, while BIT will be the firm's glycomics reference site in Southeast Asia.

Financial and other terms of the deal were not disclosed.

"With increasing use of biologics to treat human diseases, and with more biosimilars coming to market in the next few years, it is timely for BTI to develop novel technologies that would improve the characterization and analysis of protein-based drugs," BTI Executive Director Lam Kong Peng said in a statement.

The Scan

Cell Atlas of Human Lung Development Gives View of Developing Airway

Researchers have generated a cell atlas of human lung development, which they report in Cell.

Study Finds Costs of Genome Sequencing May Limit Utility in Routine Care

Researchers report in the European Journal of Human Genetics that genome sequencing for rare disease diagnoses currently has similar benefits as less expensive exome analysis.

Study Suggests Nursing Mother's Diet Can Impact Offspring's Gut Microbiome

A new Cell Host and Microbe paper finds that mice whose mothers were fed a low-fiber diet during nursing experience lasting microbiota dysbiosis and increased obesity.

Study Links Genetic Risk for ADHD With Alzheimer's Disease

A higher polygenic risk score for attention-deficit/hyperactivity disorder is also linked to cognitive decline and Alzheimer's disease, a new study in Molecular Psychiatry finds.